The week in prescription drug pricing: what moved, what it means for patients, and what comes next.
On Wednesday, January 31st, oral arguments will be heard in AstraZeneca’s legal challenge against Medicare’s ability to negotiate the price of the company’s diabetes and heart failure drug, Farxiga.
News Jan 20, 2024In the health care policy arena, the focus centers around the passage of the Lower Costs, More Transparency Act (HR 5378).
News Jan 13, 2024A recent report from The Commonwealth Fund underscores the issue at the heart of our work at Patients For Affordable Drugs: Americans are paying 3 to 8 times more for brand-name prescription…
News Jan 8, 2024Over the last 12 months, our community has been at the forefront of amplifying patient voices in the fight to lower drug prices, fighting back against pharma lies, and advocating for bills that will…
News Dec 22, 2023The pharmaceutical industry’s opposition to the new Medicare drug negotiation program introduced via the Inflation Reduction Act was back in the news this week.
News Dec 16, 2023Yesterday, President Biden visited the National Institutes of Health, to announce that dozens of pharmaceutical companies will be required to pay rebates to Medicare for excessive price hikes on…
News Dec 13, 2023As we approach the end of 2023, we wanted to highlight the historic drug price reforms in the Inflation Reduction Act delivering relief to millions of patients on Medicare.
News Dec 12, 2023NEW YORK — Over 100 patients from New York who depend on essential, high-priced medications sent a letter to Senate Majority Leader Chuck Schumer thanking him for his work to lower drug prices and…
News Nov 27, 2023Wishing everyone a restful and restorative Thanksgiving break! Here’s a roundup featuring P4AD patient advocates at the virtual CMS Listening Sessions for the Medicare Negotiation Program
News Nov 27, 2023We know that Big Pharma will go to extreme lengths to preserve its monopoly pricing power and egregious profits.
